PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 6, 2026
$45,26
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$42,62mínima 52 sem
$71,07máxima 52 sem
Capitalização de Mercado (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Receita (TTM)
$1.10B
seus distintivos
Intervalo 52 Semanas
$43–$71
Classificação do Analista
BUY
Preço-Alvo
$68
P/E
12.7
ROE
9.1%
Margem de Lucro Líquido
15.6%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
PBH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$45.26
Capitalização de Mercado (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Receita (TTM)
$1.10B
ROE (TTM)
9.1%
Dívida/Capital (MRQ)
1.1
Intervalo 52 Semanas
$43–$71
PBH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Prestige Consumer Healthcare Inc. Common Stock Visão geral da empresa da Wikipedia
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealthcare
indústriaPharmaceuticals
funcionários890
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$1.09B2017-03-31 → 2026-03-31
EPS$3.912017-03-31 → 2026-03-31
Fluxo de caixa livre$246M2017-03-31 → 2026-03-31
Margem líquida15.6%2017-03-31 → 2026-03-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | PBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 12.7média 5A ≈5.5 | ≈5.5 | · | · | |
| P/S (TTM) | 2.3média 5A ≈3.3 | ≈3.3 | · | · | |
| P/B (MRQ) | 1.3média 5A ≈2.2 | ≈2.2 | · | · | |
| Preço / FCF (TTM) | 10.8média 5A ≈15.4 | ≈15.4 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 10.2média 5A ≈14.9 | ≈14.9 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | -1.9 | · | · | · | |
| PEG Ratio | ≈3.4 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | PBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 53.5%média 5A ≈55.7% | ≈55.7% | · | · | |
| Margem Operacional (TTM) | 26.3%média 5A ≈23.4% | ≈23.4% | · | · | |
| Margem EBITDA (TTM) | 29.2%média 5A ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (Margem de Impostos Pré-Tributação) | 23.6%média 5A ≈17.8% | ≈17.8% | · | · | |
| Margem de Lucro Líquido (TTM) | 15.6%média 5A ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%média 5A ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%média 5A ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%média 5A ≈8.6% | ≈8.6% | · | · |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | PBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 1.1média 5A ≈0.8 | ≈0.8 | · | · | |
| Índice de liquidez corrente (MRQ) | 3.2média 5A ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio (Índice de Liquidez Seca) | 2.1média 5A ≈1.9 | ≈1.9 | · | · | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 1.0média 5A ≈0.8 | ≈0.8 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | PBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -4.3%média 5A ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -1.2%média 5A ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 2.9% | · | · | · | |
| EPS YoY | -8.9%média 5A ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -11.3%média 5A ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 2.0% | · | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | 2.9% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | PBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.3média 5A ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Giro de Estoque) | 3.2média 5A ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 5.6média 5A ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$1.2M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.02%
Próximo relatório
Nov 04, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | $0.98 | $0.89 | 10.0% | |
| 31 de Março de 2026 | $1.23 | $1.40 | -12.4% | |
| 31 de Dezembro de 2025 | $1.14 | $1.16 | -1.4% | |
| 30 de Setembro de 2025 | $1.07 | $0.98 | 9.2% | |
| 30 de Junho de 2025 | $0.95 | $1.01 | -6.0% | |
| 31 de Março de 2025 | $1.32 | $1.31 | 0.64% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Balanço Patrimonial
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Fluxo de Caixa
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Lucratividade
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Liquidez e Solvência
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Eficiência
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Por Ação
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Taxas de Crescimento
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Demonstração de Resultados
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Balanço Patrimonial
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Fluxo de Caixa
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Lucratividade
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Liquidez e Solvência
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Eficiência
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Por Ação
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Avaliação (TTM)
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Receita | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Margem Bruta % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Margem Operacional % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Lucro líquido | $190M | $215M | $209M | $-82M | $205M |
| EPS Diluído | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | · | · | 0.7 | 0.9 | 0.9 |
| Índice de liquidez corrente | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Índice de Liquidez Seca | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $246M | $243M | $239M | $222M | $250M |
Investidores institucionais (13F) 340 declarantes · $2.9B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
340
Valor detido
$2.9B
Novas posições
39
Posições encerradas
69
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 39 (-19 vs trimestre anterior) | 69 (+29 vs trimestre anterior) | 108 (-17 vs trimestre anterior) | 119 (-10 vs trimestre anterior) | +2.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $370.187.111 | 7.831.333 | 12,99% | Ações |
| VANGUARD GROUP INC | $332.432.481 | 5.388.758 | 11,66% | Ações |
| ARIEL INVESTMENTS, LLC | $230.143.970 | 4.868.711 | 8,07% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133.553.822 | 2.825.340 | 4,69% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $125.802.061 | 2.661.291 | 4,41% | Ações |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110.225.175 | 2.331.821 | 3,87% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $101.013.343 | 2.136.944 | 3,54% | Ações |
| STATE STREET CORP | $100.047.570 | 2.116.513 | 3,51% | Ações |
| BRANDES INVESTMENT PARTNERS, LP | $96.953.606 | 2.051.060 | 3,40% | Ações |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88.490.528 | 1.872.023 | 3,10% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $74.306.032 | 1.571.742 | 2,61% | Ações |
| Allspring Global Investments Holdings, LLC | $61.257.112 | 1.271.950 | 2,15% | Ações |
| MORGAN STANLEY | $58.800.671 | 1.243.931 | 2,06% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $39.252.108 | 828.628 | 1,38% | Ações |
| NORTHERN TRUST CORP | $36.560.934 | 773.449 | 1,28% | Ações |
| WESTWOOD HOLDINGS GROUP INC | $35.473.535 | 750.445 | 1,24% | Ações |
| RICE HALL JAMES & ASSOCIATES, LLC | $32.601.741 | 689.692 | 1,14% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31.134.811 | 658.659 | 1,09% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.922.805 | 654.174 | 1,08% | Ações |
| UBS Group AG | $30.186.858 | 638.605 | 1,06% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29.772.348 | 629.836 | 1,04% | Ações |
| Boston Trust Walden Corp | $28.832.289 | 609.949 | 1,01% | Ações |
| GOLDMAN SACHS GROUP INC | $27.725.541 | 586.536 | 0,97% | Ações |
| CITADEL ADVISORS LLC | $26.667.701 | 564.157 | 0,94% | Ações |
| BANK OF AMERICA CORP /DE/ | $26.277.109 | 555.894 | 0,92% | Ações |
| RAYMOND JAMES FINANCIAL INC | $21.949.967 | 464.353 | 0,77% | Ações |
| Leeward Investments, LLC - MA | $20.700.289 | 437.916 | 0,73% | Ações |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19.921.578 | 421.440 | 0,70% | Ações |
| Invesco Ltd. | $19.209.111 | 406.370 | 0,67% | Ações |
| Woodline Partners LP | $17.004.012 | 359.721 | 0,60% | Ações |
| ARMISTICE CAPITAL, LLC | $15.882.720 | 336.000 | 0,56% | Ações |
| Glenmede Investment Management, LP | $15.685.425 | 251.369 | 0,55% | Ações |
| Bank of New York Mellon Corp | $15.375.752 | 325.275 | 0,54% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $14.837.438 | 313.887 | 0,52% | Ações |
| D. E. Shaw & Co., Inc. | $14.832.286 | 313.778 | 0,52% | Ações |
| WELLS FARGO & COMPANY/MN | $14.604.614 | 308.962 | 0,51% | Ações |
| Nuveen, LLC | $14.012.435 | 296.434 | 0,49% | Ações |
| Congress Wealth Management LLC / DE / | $13.030.320 | 163.185 | 0,46% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $12.700.693 | 268.684 | 0,45% | Ações |
| Tributary Capital Management, LLC | $11.958.554 | 252.984 | 0,42% | Ações |
| Fisher Asset Management, LLC | $11.698.136 | 247.474 | 0,41% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $11.013.816 | 232.998 | 0,39% | Ações |
| PRUDENTIAL FINANCIAL INC | $10.251.209 | 216.865 | 0,36% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10.122.871 | 214.150 | 0,36% | Ações |
| JPMORGAN CHASE & CO | $10.050.950 | 207.249 | 0,35% | Ações |
| Aristotle Capital Boston, LLC | $10.043.458 | 212.470 | 0,35% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $9.983.703 | 211.206 | 0,35% | Ações |
| FMR LLC | $9.951.172 | 210.518 | 0,35% | Ações |
| GLENMEDE TRUST CO NA | $9.729.017 | 205.818 | 0,34% | Ações |
| JENNISON ASSOCIATES LLC | $9.393.259 | 198.715 | 0,33% | Ações |
Executivos da empresa 50 insiders · 29 diretores · 18 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 7 de Maio de 2026 F | 373.465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 1 de Junho de 2015 M | 27.706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 3 de Março de 2009 P | 177.168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 de Maio de 2006 P | 33.278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 2 de Maio de 2026 F | 57.374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 9 de Maio de 2016 A | 11.050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 de Maio de 2010 D | 401.850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 de Maio de 2026 S | 41.810 | 0 | 7 | $-246.374 |
| Adel Mekhail | EVP, Marketing & Sales | 7 de Maio de 2026 F | 25.703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 4 de Maio de 2026 A | 28.149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 6 de Janeiro de 2026 A | 3.436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 7 de Maio de 2025 F | 17.051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 9 de Maio de 2019 F | 21.717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 de Maio de 2018 M | 11.081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 7 de Maio de 2018 A | 8.150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 de Agosto de 2017 F | 6.678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 de Maio de 2017 F | 62.075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 de Maio de 2016 M | 55.927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 de Maio de 2016 M | 32.176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 de Maio de 2014 M | 15.282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 de Maio de 2011 F | 13.236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 de Maio de 2010 D | 28.331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 de Maio de 2010 D | 16.640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 de Março de 2009 D | 30.579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 de Março de 2009 D | 90.846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 de Maio de 2008 A | 27.427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 2 de Janeiro de 2007 D | 289.172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 de Fevereiro de 2005 S | 180.560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 de Fevereiro de 2005 S | 72.347 | 0 | 0 | $0 |
| Sheila Hopkins | Conselheiro | 5 de Agosto de 2025 A | 30.123 | 0 | 0 | $0 |
| Natale S Ricciardi | Conselheiro | 1 de Agosto de 2023 A | 27.098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Conselheiro | 2 de Agosto de 2022 A | 13.218 | 0 | 0 | $0 |
| James M Jenness | Conselheiro | 4 de Agosto de 2020 A | 22.791 | 0 | 0 | $0 |
| Carl J Johnson | Conselheiro | 31 de Julho de 2018 A | 14.598 | 0 | 0 | $0 |
| Charles Hinkaty | Conselheiro | 4 de Agosto de 2015 A | 31.714 | 0 | 0 | $0 |
| Patrick Lonergan | Conselheiro | 10 de Dezembro de 2012 G | 37.323 | 0 | 0 | $0 |
| John Byom | Conselheiro | 3 de Agosto de 2010 A | 29.755 | 0 | 0 | $0 |
| Vincent J Hemmer | Conselheiro | 10 de Setembro de 2009 J | 80.410 | 0 | 0 | $0 |
| Peter Mann | Conselheiro | 4 de Agosto de 2009 A | 447.700 | 0 | 0 | $0 |
| Dick L Buell | Conselheiro | 4 de Agosto de 2009 A | 27.662 | 0 | 0 | $0 |
| David Donnini | Conselheiro | 29 de Maio de 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Conselheiro | 5 de Agosto de 2008 A | 30.352 | 0 | 0 | $0 |
| Raymond Silcock | Conselheiro | 5 de Agosto de 2008 A | 16.249 | 0 | 0 | $0 |
| John F. Kelly | · | 4 de Agosto de 2026 A | 7.832 | 0 | 0 | $0 |
| James Darecca | · | 4 de Agosto de 2026 A | 9.572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 4 de Agosto de 2026 A | 19.514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 4 de Agosto de 2026 A | 16.511 | 0 | 0 | $0 |
| John E Byom | · | 4 de Agosto de 2026 A | 54.575 | 0 | 1 | $-178.050 |
| COSTLEY GARY E | · | 4 de Agosto de 2020 A | 50.200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 de Maio de 2009 S | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 67 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,83% | 347.516 SH | 2 de Outubro de 2026 | Diário |
| PILL · Direxion Shares ETF Trust | 1,16% | 4.781 NS | 31 de Julho de 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 44.987 SH | 2 de Outubro de 2026 | Diário |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5.597 NS | 31 de Julho de 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25.280 NS | 31 de Julho de 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 de Julho de 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3.105 NS | 31 de Julho de 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175.342 SH | 11 de Setembro de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92.272 NS | 31 de Julho de 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181.211 NS | 31 de Julho de 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100.520 SH | 19 de Agosto de 2026 | Diário |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18.534 NS | 31 de Julho de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41.965 SH | 19 de Agosto de 2026 | Diário |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7.601 SH | 2 de Outubro de 2026 | Diário |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4.372 NS | 31 de Julho de 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165.811 SH | 19 de Agosto de 2026 | Diário |
| ROSC · Lattice Strategies Trust | 0,12% | 1.466 NS | 31 de Julho de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195.077 NS | 31 de Julho de 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8.172 SH | 2 de Outubro de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 66.578 SH | 2 de Outubro de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 de Julho de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1.747 NS | 31 de Julho de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43.685 NS | 31 de Julho de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11.789 NS | 31 de Julho de 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7.246 SH | 19 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,08% | 22.923 NS | 31 de Julho de 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1.227.360 SH | 11 de Setembro de 2026 | Diário |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175.325 SH | 19 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275.721 SH | 19 de Agosto de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,07% | 196.959 NS | 31 de Julho de 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28.777 SH | 2 de Outubro de 2026 | Diário |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690.582 SH | 19 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,05% | 152.317 NS | 31 de Julho de 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10.967 SH | 11 de Setembro de 2026 | Diário |
| WSML · iShares Trust | 0,04% | 5.420 SH | 11 de Setembro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22.700 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544.134 SH | 19 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.087.231 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,03% | 142.413 SH | 19 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,01% | 117.382 NS | 31 de Julho de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36.640 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5.233 NS | 31 de Julho de 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688.472 SH | 19 de Agosto de 2026 | Diário |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453.610 SH | 19 de Agosto de 2026 | Diário |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9.203 SH | 19 de Agosto de 2026 | Diário |
| IDEV · iShares Trust | 0,01% | 52.014 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.004 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.442 NS | 31 de Julho de 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56.667 SH | 11 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,00% | 69.137 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 14.019 SH | 11 de Setembro de 2026 | Diário |
| DFAU · Dimensional ETF Trust | 0,00% | 6.651 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.940 NS | 31 de Julho de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.510.012 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69.368 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.089 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10.506 SH | 19 de Agosto de 2026 | Diário |
| IJR · iShares Trust | · | 2.889.316 SH | 10 de Setembro de 2026 | Diário |
| IJS · iShares Trust | · | 422.466 SH | 8 de Setembro de 2026 | Diário |
| IWN · iShares Trust | · | 449.434 SH | 11 de Setembro de 2026 | Diário |
| XJR · iShares Trust | · | 6.541 SH | 31 de Agosto de 2026 | Diário |
| SVAL · iShares Trust | · | 10.792 SH | 3 de Setembro de 2026 | Diário |
| ISCB · iShares Trust | · | 1.977 SH | 11 de Setembro de 2026 | Diário |
| ISCV · iShares Trust | · | 9.565 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 38.488 SH | 11 de Setembro de 2026 | Diário |
| SMMV · iShares Trust | · | 20.132 SH | 25 de Agosto de 2026 | Diário |
PBH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 10 analistas
COMPRA
Alvo mediano
$70.00
+54,7%
3 30,0%
Compra forte
4 40,0%
Compra
3 30,0%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
5 analistas · 2026-10-03Alvo médio $67.80 +49,8%
← Abaixo de todos os alvos
Preço atual $45.26
Mín$55.00
Média$67.80
Máx$75.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 6, 2026